Value Bridge — SHARP CHULA VISTA MEDICAL CENTER
Current $-50M → Target $-39M (+$11.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-50.0M
Current EBITDA
$-38.5M
Target EBITDA
+$11.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.6M
Payer Mix Optimization
$6.2M
Cost to Collect Reduction
$2.1M
Clean Claim Improvement
$1.6M
Volume & Rate Growth
$10.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-50M to $-39M. The highest-impact lever is Volume & Rate Growth at $4.2M probability-weighted.
IC talking point: "We see $11M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $126M in equity value creation."